Dr. David S. Boisoneau, MD

Dr. Boisoneau practices at Ear,nose And Throat Associates Of Southeastern Connecticut in Waterford, Connecticut.

Dr. Boisoneau's NPI, 1467429597, was assigned on March 7, 2006. Dr. Boisoneau graduated from University of Connecticut in 1995. Dr. Boisoneau holds Connecticut license 036632.

Dr. Boisoneau's primary practice is Ear,nose and Throat Associates of Southeastern Connecticut, at 201 Boston Post Rd, Waterford, CT 06385-2805. The practice phone is (860) 442-0407.

Dr. Boisoneau's primary practice is Ear,nose And Throat Associates Of Southeastern Connecticut in Waterford, Connecticut. Dr. Boisoneau is also affiliated with Lawrence + Memorial Hospital. The medical group on file is Ear, Nose & Throat Associates of SECT. Dmand AI also links Dr. Boisoneau to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boisoneau practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Boisoneau's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Boisoneau is licensed in Connecticut.

CMS data shows 1,554 Medicare services from Dr. Boisoneau across 9 procedure codes in 2024, for 355 Medicare patients. Medicare paid $66,848 for them. Every service was in an office.

CMS counts 355 Medicare patients who saw Dr. Boisoneau in 2024. The largest group is 75 to 84, with 139 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Boisoneau's median patient age at 66, with 55% women.

In 2024, Dr. Boisoneau wrote 795 Medicare Part D claims for 259 patients. 87% of them were for generic drugs. CMS names the drug for 700 of them, across 21 drugs with 11 or more claims each, at $184,428 in total drug cost. In 2023, CMS named 742 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Boisoneau for performance year 2024, reported as part of a group. Dr. Boisoneau accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Boisoneau. The most frequent topics are Analgesics, Opioid, Drug Prescriptions and Otorhinolaryngologic Surgical Procedures. Dr. Boisoneau has published most often in Otolaryngol Head Neck Surg. Dr. Boisoneau's most frequent co-authors are Samantha Anne, MD, Michael Joel Brenner, MD and David Michael Dickerson, MD.

CMS Open Payments shows 155 general payments to Dr. Boisoneau from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Sanofi and Genzyme US Companies paid the most, $1,617.

Dr. Boisoneau graduated from University of Connecticut in 1995.